NRX Historical Balance Sheet

NRXP Stock  USD 2.99  0.15  4.78%   
Trend analysis of NRX Pharmaceuticals balance sheet accounts such as Net Debt of 4.3 M provides information on NRX Pharmaceuticals' total assets, liabilities, and equity, which is the actual value of NRX Pharmaceuticals to its prevalent stockholders. By breaking down trends over time using NRX Pharmaceuticals balance sheet statements, investors will see what precisely the company owns and what it owes to creditors or other parties at the end of each accounting year.
 
Covid
Financial Statement Analysis is much more than just reviewing and examining NRX Pharmaceuticals latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether NRX Pharmaceuticals is a good buy for the upcoming year.

NRX Pharmaceuticals Inventory

(5,130)

  
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in NRX Pharmaceuticals. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in interest.
To learn how to invest in NRX Stock, please use our How to Invest in NRX Pharmaceuticals guide.

About NRX Balance Sheet Analysis

Balance Sheet is a snapshot of the financial position of NRX Pharmaceuticals at a specified time, usually calculated after every quarter, six months, or one year. NRX Pharmaceuticals Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of NRX Pharmaceuticals and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which NRX currently owns. An asset can also be divided into two categories, current and non-current.

NRX Pharmaceuticals Balance Sheet Chart

At this time, NRX Pharmaceuticals' Other Current Assets are relatively stable compared to the past year. As of 01/31/2025, Other Stockholder Equity is likely to grow to about 291.4 M, though Total Stockholder Equity is likely to grow to (10 M).

Total Assets

Total assets refers to the total amount of NRX Pharmaceuticals assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in NRX Pharmaceuticals books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. The total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets.

Total Current Liabilities

Total Current Liabilities is an item on NRX Pharmaceuticals balance sheet that include short term debt, accounts payable, accrued salaries payable, payroll taxes payable, accrued liabilities and other debts. Total Current Liabilities of NRX Pharmaceuticals are important to investors because some useful performance ratios such as Current Ratio and Quick Ratio require Total Current Liabilities to be accurate. The total amount of liabilities that a company is expected to pay within one year, including debts, accounts payable, and other short-term financial obligations.

Accounts Payable

An accounting item on the balance sheet that represents NRX Pharmaceuticals obligation to pay off a short-term debt to its creditors. The accounts payable entry is usually reported under current liabilities. If accounts payable of NRX Pharmaceuticals are not paid within the agreed terms, the payables are considered to be in default, which may trigger a penalty or interest payment, or the revocation of additional credit from the supplier. Accounts payable may also be considered a source of cash, since they represent funds being borrowed from suppliers. Given these cash flow considerations, suppliers have a natural inclination to push for shorter payment terms, while creditors want to lengthen the payment terms. The amount a company owes to suppliers or vendors for products or services received but not yet paid for. It represents the company's short-term liabilities.

Non Currrent Assets Other

Assets that are not physical or tangible, expected to provide value for more than one year, and not easily converted into cash, such as long-term investments or patents.
Most accounts from NRX Pharmaceuticals' balance sheet are interrelated and interconnected. However, analyzing balance sheet accounts one by one will only give a small insight into NRX Pharmaceuticals current financial condition. On the other hand, looking into the entire matrix of balance sheet accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in NRX Pharmaceuticals. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in interest.
To learn how to invest in NRX Stock, please use our How to Invest in NRX Pharmaceuticals guide.At this time, NRX Pharmaceuticals' Other Current Assets are relatively stable compared to the past year. As of 01/31/2025, Other Stockholder Equity is likely to grow to about 291.4 M, though Total Stockholder Equity is likely to grow to (10 M).
 2022 2023 2024 2025 (projected)
Other Current Liabilities5.8M5.3M6.0M9.7M
Total Assets25.8M7.3M6.6M6.3M

NRX Pharmaceuticals balance sheet Correlations

-0.63-0.840.980.00.85-0.91-0.440.97-0.67-0.440.97-0.470.970.92-0.47-0.82-0.85-0.480.97-0.74-0.950.0-0.080.820.74
-0.630.92-0.75-0.08-0.330.470.16-0.580.120.16-0.570.47-0.58-0.590.10.220.910.17-0.570.110.53-0.03-0.6-0.55-0.14
-0.840.92-0.92-0.05-0.650.720.31-0.80.390.31-0.790.55-0.8-0.840.330.541.00.35-0.790.440.79-0.07-0.33-0.78-0.46
0.98-0.75-0.920.020.81-0.88-0.420.95-0.59-0.420.95-0.520.950.92-0.45-0.75-0.93-0.460.95-0.66-0.920.010.050.830.67
0.0-0.08-0.050.020.19-0.05-0.820.240.34-0.820.23-0.70.230.28-0.5-0.16-0.05-0.790.230.21-0.24-0.92-0.35-0.350.29
0.85-0.33-0.650.810.19-0.92-0.680.91-0.72-0.680.9-0.580.910.93-0.72-0.98-0.65-0.720.9-0.86-0.9-0.08-0.480.750.97
-0.910.470.72-0.88-0.05-0.920.51-0.90.790.51-0.90.37-0.9-0.890.450.920.720.54-0.90.780.88-0.040.33-0.74-0.87
-0.440.160.31-0.42-0.82-0.680.51-0.650.141.0-0.640.84-0.65-0.670.840.670.321.0-0.640.380.640.730.58-0.15-0.76
0.97-0.58-0.80.950.240.91-0.9-0.65-0.59-0.651.0-0.651.00.97-0.64-0.88-0.82-0.691.0-0.72-0.98-0.21-0.230.740.84
-0.670.120.39-0.590.34-0.720.790.14-0.590.14-0.58-0.07-0.59-0.560.190.770.380.17-0.580.790.57-0.40.38-0.68-0.69
-0.440.160.31-0.42-0.82-0.680.511.0-0.650.14-0.640.84-0.65-0.670.840.670.321.0-0.640.380.640.730.58-0.15-0.76
0.97-0.57-0.790.950.230.9-0.9-0.641.0-0.58-0.64-0.641.00.96-0.63-0.87-0.81-0.681.0-0.72-0.98-0.22-0.220.730.83
-0.470.470.55-0.52-0.7-0.580.370.84-0.65-0.070.84-0.64-0.64-0.690.860.490.570.86-0.640.320.640.580.14-0.35-0.55
0.97-0.58-0.80.950.230.91-0.9-0.651.0-0.59-0.651.0-0.640.97-0.64-0.87-0.81-0.681.0-0.72-0.98-0.21-0.230.730.83
0.92-0.59-0.840.920.280.93-0.89-0.670.97-0.56-0.670.96-0.690.97-0.66-0.86-0.84-0.70.96-0.7-0.98-0.19-0.220.740.84
-0.470.10.33-0.45-0.5-0.720.450.84-0.640.190.84-0.630.86-0.64-0.660.70.350.86-0.630.640.640.420.5-0.45-0.76
-0.820.220.54-0.75-0.16-0.980.920.67-0.880.770.67-0.870.49-0.87-0.860.70.540.7-0.870.90.860.070.58-0.7-0.98
-0.850.911.0-0.93-0.05-0.650.720.32-0.820.380.32-0.810.57-0.81-0.840.350.540.36-0.810.460.8-0.06-0.33-0.78-0.47
-0.480.170.35-0.46-0.79-0.720.541.0-0.690.171.0-0.680.86-0.68-0.70.860.70.36-0.680.430.680.690.58-0.21-0.79
0.97-0.57-0.790.950.230.9-0.9-0.641.0-0.58-0.641.0-0.641.00.96-0.63-0.87-0.81-0.68-0.72-0.98-0.22-0.220.730.83
-0.740.110.44-0.660.21-0.860.780.38-0.720.790.38-0.720.32-0.72-0.70.640.90.460.43-0.720.71-0.260.45-0.84-0.84
-0.950.530.79-0.92-0.24-0.90.880.64-0.980.570.64-0.980.64-0.98-0.980.640.860.80.68-0.980.710.230.25-0.71-0.83
0.0-0.03-0.070.01-0.92-0.08-0.040.73-0.21-0.40.73-0.220.58-0.21-0.190.420.07-0.060.69-0.22-0.260.230.350.45-0.2
-0.08-0.6-0.330.05-0.35-0.480.330.58-0.230.380.58-0.220.14-0.23-0.220.50.58-0.330.58-0.220.450.250.350.08-0.67
0.82-0.55-0.780.83-0.350.75-0.74-0.150.74-0.68-0.150.73-0.350.730.74-0.45-0.7-0.78-0.210.73-0.84-0.710.450.080.6
0.74-0.14-0.460.670.290.97-0.87-0.760.84-0.69-0.760.83-0.550.830.84-0.76-0.98-0.47-0.790.83-0.84-0.83-0.2-0.670.6
Click cells to compare fundamentals

NRX Pharmaceuticals Account Relationship Matchups

NRX Pharmaceuticals balance sheet Accounts

202020212022202320242025 (projected)
Total Assets2.9M32.7M25.8M7.3M6.6M6.3M
Other Current Liab42.7M7.7M5.8M5.3M6.0M9.7M
Total Current Liabilities46.2M11.9M16.6M19.0M21.9M14.9M
Total Stockholder Equity(43.8M)20.8M7.4M(11.7M)(10.6M)(10.0M)
Net Debt(1.1M)(27.1M)(9.5M)4.6M4.1M4.3M
Retained Earnings(90.2M)(183.2M)(223.1M)(253.1M)(227.8M)(216.4M)
Accounts Payable3.2M3.7M2.1M4.6M5.3M5.6M
Cash1.9M27.6M20.1M4.6M5.3M8.6M
Non Current Assets Total11K15K21K431K387.9K368.5K
Non Currrent Assets Other11K15K21K431K495.7K520.4K
Cash And Short Term Investments1.9M27.6M20.1M4.6M5.3M8.6M
Common Stock Shares Outstanding34.3M46.9M65.8M7.6M8.7M8.3M
Liabilities And Stockholders Equity2.9M32.7M25.8M7.3M6.6M6.3M
Other Current Assets240K5.1M11.5M2.3M2.6M3.0M
Other Stockholder Equity46.4M204.0M230.3M241.3M277.5M291.4M
Total Liab46.7M11.9M18.4M19.0M21.9M15.7M
Total Current Assets2.9M32.7M25.8M6.9M7.9M10.8M
Common Stock43K59K67K84K75.6K71.8K
Short Long Term Debt Total797K518K10.5M9.2M10.5M11.1M

Pair Trading with NRX Pharmaceuticals

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if NRX Pharmaceuticals position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in NRX Pharmaceuticals will appreciate offsetting losses from the drop in the long position's value.

Moving against NRX Stock

  0.75KRYS Krystal BiotechPairCorr
  0.66INZY Inozyme PharmaPairCorr
  0.6PDSB PDS Biotechnology CorpPairCorr
  0.58MREO Mereo BioPharma GroupPairCorr
  0.55JNJ Johnson JohnsonPairCorr
The ability to find closely correlated positions to NRX Pharmaceuticals could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace NRX Pharmaceuticals when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back NRX Pharmaceuticals - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling NRX Pharmaceuticals to buy it.
The correlation of NRX Pharmaceuticals is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as NRX Pharmaceuticals moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if NRX Pharmaceuticals moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for NRX Pharmaceuticals can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Additional Tools for NRX Stock Analysis

When running NRX Pharmaceuticals' price analysis, check to measure NRX Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy NRX Pharmaceuticals is operating at the current time. Most of NRX Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of NRX Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move NRX Pharmaceuticals' price. Additionally, you may evaluate how the addition of NRX Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.